News

Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies for COVID-19 therapy

 The Council of Scientific and Industrial Research (CSIR) has sanctioned development of human monoclonal antibodies as therapy for COVID-19 infections.

Read More

May 08, 2020

By : Team ABLE

Lab-grown mini human organs to accelerate COVID-19 drug development research

In these human organ-like structures, scientists are beginning to perform more experiments to explore how the SARS-CoV-2 virus replicates in hosts, or even test vaccines and drugs against COVID-19.

Read More

May 08, 2020

By : TeamABLE

CSIR contributes 53 entries to global Coronavirus genome database

CSIR has submitted as many as 53 genome sequences of the novel coronavirus (COVID-19) to a global genome database.

Read More

May 08, 2020

By : Team ABLE

DBT seeks Letters of Intent from scientists for setting up Cancer Virtual Network Centers

DBT has invited Letters of Intent (LoI) in the area of Cancer Immunology & Immunotherapy from eligible scientists and clinicians for setting-up of Virtual Network Centers (VNCs) for a period of five years.

Read More

May 08, 2020

By : Team ABLE

Lilly, Junshi Biosciences to co-develop antibody-based therapies for COVID-19

Lilly will receive an exclusive license to conduct clinical development, manufacturing and distribution of products outside of Greater China.

Read More

May 07, 2020

By : By Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights